Imatinib Drugs Market - Global Outlook and Forecast 2022-2028

March 2022 | 79 pages | ID: I75AE87FC4ECEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Imatinib Drugs in global, including the following market information:

Global Imatinib Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Imatinib Drugs Market Sales, 2017-2022, 2023-2028, (K MT)

Global top five Imatinib Drugs companies in 2021 (%)

The global Imatinib Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Capsules Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Imatinib Drugs include Apotex Inc., Novartis, Sanofi S.A., Cipla Inc., Mylan Pharms Inc., Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals, Actavis Generics and Dr. Reddy's Laboratories and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Imatinib Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Imatinib Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Imatinib Drugs Market Segment Percentages, by Type, 2021 (%)

• Capsules
• Tablets

Global Imatinib Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Imatinib Drugs Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Drug Stores
• Others

Global Imatinib Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Imatinib Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Imatinib Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Imatinib Drugs revenues share in global market, 2021 (%)

Key companies Imatinib Drugs sales in global market, 2017-2022 (Estimated), (K MT)

Key companies Imatinib Drugs sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Apotex Inc.
• Novartis
• Sanofi S.A.
• Cipla Inc.
• Mylan Pharms Inc.
• Glenmark Pharmaceuticals Ltd.
• Sun Pharmaceuticals
• Actavis Generics
• Dr. Reddy's Laboratories
• Teva Pharmaceutical Industries Ltd.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Imatinib Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Imatinib Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IMATINIB DRUGS OVERALL MARKET SIZE

2.1 Global Imatinib Drugs Market Size: 2021 VS 2028
2.2 Global Imatinib Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Imatinib Drugs Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Imatinib Drugs Players in Global Market
3.2 Top Global Imatinib Drugs Companies Ranked by Revenue
3.3 Global Imatinib Drugs Revenue by Companies
3.4 Global Imatinib Drugs Sales by Companies
3.5 Global Imatinib Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Imatinib Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Imatinib Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Imatinib Drugs Players in Global Market
  3.8.1 List of Global Tier 1 Imatinib Drugs Companies
  3.8.2 List of Global Tier 2 and Tier 3 Imatinib Drugs Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Imatinib Drugs Market Size Markets, 2021 & 2028
  4.1.2 Capsules
  4.1.3 Tablets
4.2 By Type - Global Imatinib Drugs Revenue & Forecasts
  4.2.1 By Type - Global Imatinib Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Imatinib Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Imatinib Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Imatinib Drugs Sales & Forecasts
  4.3.1 By Type - Global Imatinib Drugs Sales, 2017-2022
  4.3.2 By Type - Global Imatinib Drugs Sales, 2023-2028
  4.3.3 By Type - Global Imatinib Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Imatinib Drugs Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Imatinib Drugs Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Drug Stores
  5.1.4 Others
5.2 By Application - Global Imatinib Drugs Revenue & Forecasts
  5.2.1 By Application - Global Imatinib Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Imatinib Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Imatinib Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Imatinib Drugs Sales & Forecasts
  5.3.1 By Application - Global Imatinib Drugs Sales, 2017-2022
  5.3.2 By Application - Global Imatinib Drugs Sales, 2023-2028
  5.3.3 By Application - Global Imatinib Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Imatinib Drugs Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Imatinib Drugs Market Size, 2021 & 2028
6.2 By Region - Global Imatinib Drugs Revenue & Forecasts
  6.2.1 By Region - Global Imatinib Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Imatinib Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Imatinib Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Imatinib Drugs Sales & Forecasts
  6.3.1 By Region - Global Imatinib Drugs Sales, 2017-2022
  6.3.2 By Region - Global Imatinib Drugs Sales, 2023-2028
  6.3.3 By Region - Global Imatinib Drugs Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Imatinib Drugs Revenue, 2017-2028
  6.4.2 By Country - North America Imatinib Drugs Sales, 2017-2028
  6.4.3 US Imatinib Drugs Market Size, 2017-2028
  6.4.4 Canada Imatinib Drugs Market Size, 2017-2028
  6.4.5 Mexico Imatinib Drugs Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Imatinib Drugs Revenue, 2017-2028
  6.5.2 By Country - Europe Imatinib Drugs Sales, 2017-2028
  6.5.3 Germany Imatinib Drugs Market Size, 2017-2028
  6.5.4 France Imatinib Drugs Market Size, 2017-2028
  6.5.5 U.K. Imatinib Drugs Market Size, 2017-2028
  6.5.6 Italy Imatinib Drugs Market Size, 2017-2028
  6.5.7 Russia Imatinib Drugs Market Size, 2017-2028
  6.5.8 Nordic Countries Imatinib Drugs Market Size, 2017-2028
  6.5.9 Benelux Imatinib Drugs Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Imatinib Drugs Revenue, 2017-2028
  6.6.2 By Region - Asia Imatinib Drugs Sales, 2017-2028
  6.6.3 China Imatinib Drugs Market Size, 2017-2028
  6.6.4 Japan Imatinib Drugs Market Size, 2017-2028
  6.6.5 South Korea Imatinib Drugs Market Size, 2017-2028
  6.6.6 Southeast Asia Imatinib Drugs Market Size, 2017-2028
  6.6.7 India Imatinib Drugs Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Imatinib Drugs Revenue, 2017-2028
  6.7.2 By Country - South America Imatinib Drugs Sales, 2017-2028
  6.7.3 Brazil Imatinib Drugs Market Size, 2017-2028
  6.7.4 Argentina Imatinib Drugs Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Imatinib Drugs Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Imatinib Drugs Sales, 2017-2028
  6.8.3 Turkey Imatinib Drugs Market Size, 2017-2028
  6.8.4 Israel Imatinib Drugs Market Size, 2017-2028
  6.8.5 Saudi Arabia Imatinib Drugs Market Size, 2017-2028
  6.8.6 UAE Imatinib Drugs Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Apotex Inc.
  7.1.1 Apotex Inc. Corporate Summary
  7.1.2 Apotex Inc. Business Overview
  7.1.3 Apotex Inc. Imatinib Drugs Major Product Offerings
  7.1.4 Apotex Inc. Imatinib Drugs Sales and Revenue in Global (2017-2022)
  7.1.5 Apotex Inc. Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Imatinib Drugs Major Product Offerings
  7.2.4 Novartis Imatinib Drugs Sales and Revenue in Global (2017-2022)
  7.2.5 Novartis Key News
7.3 Sanofi S.A.
  7.3.1 Sanofi S.A. Corporate Summary
  7.3.2 Sanofi S.A. Business Overview
  7.3.3 Sanofi S.A. Imatinib Drugs Major Product Offerings
  7.3.4 Sanofi S.A. Imatinib Drugs Sales and Revenue in Global (2017-2022)
  7.3.5 Sanofi S.A. Key News
7.4 Cipla Inc.
  7.4.1 Cipla Inc. Corporate Summary
  7.4.2 Cipla Inc. Business Overview
  7.4.3 Cipla Inc. Imatinib Drugs Major Product Offerings
  7.4.4 Cipla Inc. Imatinib Drugs Sales and Revenue in Global (2017-2022)
  7.4.5 Cipla Inc. Key News
7.5 Mylan Pharms Inc.
  7.5.1 Mylan Pharms Inc. Corporate Summary
  7.5.2 Mylan Pharms Inc. Business Overview
  7.5.3 Mylan Pharms Inc. Imatinib Drugs Major Product Offerings
  7.5.4 Mylan Pharms Inc. Imatinib Drugs Sales and Revenue in Global (2017-2022)
  7.5.5 Mylan Pharms Inc. Key News
7.6 Glenmark Pharmaceuticals Ltd.
  7.6.1 Glenmark Pharmaceuticals Ltd. Corporate Summary
  7.6.2 Glenmark Pharmaceuticals Ltd. Business Overview
  7.6.3 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Major Product Offerings
  7.6.4 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales and Revenue in Global (2017-2022)
  7.6.5 Glenmark Pharmaceuticals Ltd. Key News
7.7 Sun Pharmaceuticals
  7.7.1 Sun Pharmaceuticals Corporate Summary
  7.7.2 Sun Pharmaceuticals Business Overview
  7.7.3 Sun Pharmaceuticals Imatinib Drugs Major Product Offerings
  7.7.4 Sun Pharmaceuticals Imatinib Drugs Sales and Revenue in Global (2017-2022)
  7.7.5 Sun Pharmaceuticals Key News
7.8 Actavis Generics
  7.8.1 Actavis Generics Corporate Summary
  7.8.2 Actavis Generics Business Overview
  7.8.3 Actavis Generics Imatinib Drugs Major Product Offerings
  7.8.4 Actavis Generics Imatinib Drugs Sales and Revenue in Global (2017-2022)
  7.8.5 Actavis Generics Key News
7.9 Dr. Reddy's Laboratories
  7.9.1 Dr. Reddy's Laboratories Corporate Summary
  7.9.2 Dr. Reddy's Laboratories Business Overview
  7.9.3 Dr. Reddy's Laboratories Imatinib Drugs Major Product Offerings
  7.9.4 Dr. Reddy's Laboratories Imatinib Drugs Sales and Revenue in Global (2017-2022)
  7.9.5 Dr. Reddy's Laboratories Key News
7.10 Teva Pharmaceutical Industries Ltd.
  7.10.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
  7.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
  7.10.3 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Major Product Offerings
  7.10.4 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales and Revenue in Global (2017-2022)
  7.10.5 Teva Pharmaceutical Industries Ltd. Key News

8 GLOBAL IMATINIB DRUGS PRODUCTION CAPACITY, ANALYSIS

8.1 Global Imatinib Drugs Production Capacity, 2017-2028
8.2 Imatinib Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Imatinib Drugs Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 IMATINIB DRUGS SUPPLY CHAIN ANALYSIS

10.1 Imatinib Drugs Industry Value Chain
10.2 Imatinib Drugs Upstream Market
10.3 Imatinib Drugs Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Imatinib Drugs Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Imatinib Drugs in Global Market
Table 2. Top Imatinib Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Imatinib Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Imatinib Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Imatinib Drugs Sales by Companies, (K MT), 2017-2022
Table 6. Global Imatinib Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Imatinib Drugs Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Imatinib Drugs Product Type
Table 9. List of Global Tier 1 Imatinib Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Imatinib Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Imatinib Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Imatinib Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Imatinib Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Imatinib Drugs Sales (K MT), 2017-2022
Table 15. By Type - Global Imatinib Drugs Sales (K MT), 2023-2028
Table 16. By Application – Global Imatinib Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Imatinib Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Imatinib Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Imatinib Drugs Sales (K MT), 2017-2022
Table 20. By Application - Global Imatinib Drugs Sales (K MT), 2023-2028
Table 21. By Region – Global Imatinib Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Imatinib Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Imatinib Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Imatinib Drugs Sales (K MT), 2017-2022
Table 25. By Region - Global Imatinib Drugs Sales (K MT), 2023-2028
Table 26. By Country - North America Imatinib Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Imatinib Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Imatinib Drugs Sales, (K MT), 2017-2022
Table 29. By Country - North America Imatinib Drugs Sales, (K MT), 2023-2028
Table 30. By Country - Europe Imatinib Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Imatinib Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Imatinib Drugs Sales, (K MT), 2017-2022
Table 33. By Country - Europe Imatinib Drugs Sales, (K MT), 2023-2028
Table 34. By Region - Asia Imatinib Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Imatinib Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Imatinib Drugs Sales, (K MT), 2017-2022
Table 37. By Region - Asia Imatinib Drugs Sales, (K MT), 2023-2028
Table 38. By Country - South America Imatinib Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Imatinib Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Imatinib Drugs Sales, (K MT), 2017-2022
Table 41. By Country - South America Imatinib Drugs Sales, (K MT), 2023-2028
Table 42. By Country - Middle East & Africa Imatinib Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Imatinib Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Imatinib Drugs Sales, (K MT), 2017-2022
Table 45. By Country - Middle East & Africa Imatinib Drugs Sales, (K MT), 2023-2028
Table 46. Apotex Inc. Corporate Summary
Table 47. Apotex Inc. Imatinib Drugs Product Offerings
Table 48. Apotex Inc. Imatinib Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Novartis Corporate Summary
Table 50. Novartis Imatinib Drugs Product Offerings
Table 51. Novartis Imatinib Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Sanofi S.A. Corporate Summary
Table 53. Sanofi S.A. Imatinib Drugs Product Offerings
Table 54. Sanofi S.A. Imatinib Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Cipla Inc. Corporate Summary
Table 56. Cipla Inc. Imatinib Drugs Product Offerings
Table 57. Cipla Inc. Imatinib Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Mylan Pharms Inc. Corporate Summary
Table 59. Mylan Pharms Inc. Imatinib Drugs Product Offerings
Table 60. Mylan Pharms Inc. Imatinib Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. Glenmark Pharmaceuticals Ltd. Corporate Summary
Table 62. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Product Offerings
Table 63. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Sun Pharmaceuticals Corporate Summary
Table 65. Sun Pharmaceuticals Imatinib Drugs Product Offerings
Table 66. Sun Pharmaceuticals Imatinib Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. Actavis Generics Corporate Summary
Table 68. Actavis Generics Imatinib Drugs Product Offerings
Table 69. Actavis Generics Imatinib Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. Dr. Reddy's Laboratories Corporate Summary
Table 71. Dr. Reddy's Laboratories Imatinib Drugs Product Offerings
Table 72. Dr. Reddy's Laboratories Imatinib Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 73. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 74. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Product Offerings
Table 75. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 76. Imatinib Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2020-2022 (K MT)
Table 77. Global Imatinib Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Imatinib Drugs Production by Region, 2017-2022 (K MT)
Table 79. Global Imatinib Drugs Production by Region, 2023-2028 (K MT)
Table 80. Imatinib Drugs Market Opportunities & Trends in Global Market
Table 81. Imatinib Drugs Market Drivers in Global Market
Table 82. Imatinib Drugs Market Restraints in Global Market
Table 83. Imatinib Drugs Raw Materials
Table 84. Imatinib Drugs Raw Materials Suppliers in Global Market
Table 85. Typical Imatinib Drugs Downstream
Table 86. Imatinib Drugs Downstream Clients in Global Market
Table 87. Imatinib Drugs Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Imatinib Drugs Segment by Type
Figure 2. Imatinib Drugs Segment by Application
Figure 3. Global Imatinib Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Imatinib Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Imatinib Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Imatinib Drugs Sales in Global Market: 2017-2028 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Imatinib Drugs Revenue in 2021
Figure 9. By Type - Global Imatinib Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Imatinib Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Imatinib Drugs Price (USD/MT), 2017-2028
Figure 12. By Application - Global Imatinib Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Imatinib Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Imatinib Drugs Price (USD/MT), 2017-2028
Figure 15. By Region - Global Imatinib Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Imatinib Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Imatinib Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Imatinib Drugs Sales Market Share, 2017-2028
Figure 19. US Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Imatinib Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Imatinib Drugs Sales Market Share, 2017-2028
Figure 24. Germany Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Imatinib Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Imatinib Drugs Sales Market Share, 2017-2028
Figure 33. China Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Imatinib Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Imatinib Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Imatinib Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Imatinib Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Imatinib Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Imatinib Drugs Production Capacity (K MT), 2017-2028
Figure 49. The Percentage of Production Imatinib Drugs by Region, 2021 VS 2028
Figure 50. Imatinib Drugs Industry Value Chain
Figure 51. Marketing Channels